These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20585729)

  • 21. The association between periodontitis and dyslipidemia based on the Fourth Korea National Health and Nutrition Examination Survey.
    Lee JB; Yi HY; Bae KH
    J Clin Periodontol; 2013 May; 40(5):437-42. PubMed ID: 23480442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: National Health and Nutrition Examination Survey 2005-2008.
    Christian JB; Bourgeois NE; Lowe KA
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):714-22. PubMed ID: 21881447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006.
    Barquera S; Campos-Nonato I; Hernández-Barrera L; Villalpando S; Rodríguez-Gilabert C; Durazo-Arvizú R; Aguilar-Salinas CA
    Salud Publica Mex; 2010; 52 Suppl 1():S63-71. PubMed ID: 20585731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
    Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
    Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertriglyceridemia and low HDL cholesterol as high impact factors for metabolic syndrome diagnosis in apparently healthy adults].
    Cifuentes-Goches JC; Gómez-López Jde D; Hernández-Ancheyta L; Flores-Fuentes SE; Incháustegui-Árias JL; Cañas-Urbina AO
    Rev Med Inst Mex Seguro Soc; 2012; 50(3):301-6. PubMed ID: 23182260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
    Zdrojewski T; Solnica B; Cybulska B; Bandosz P; Rutkowski M; Stokwiszewski J; Gaciong Z; Banach M; Wojtyniak B; Pencina M; Wyrzykowski B
    Kardiol Pol; 2016; 74(3):213-23. PubMed ID: 27004543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characterization of lipid profile in primary health care users in Portugal].
    Cortez-Dias N; Robalo Martins S; Belo A; Fiúza M;
    Rev Port Cardiol; 2013 Dec; 32(12):987-96. PubMed ID: 24280078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of breastfeeding duration with dyslipidemia in women aged over 20 years: Korea National Health and Nutrition Examination Survey 2010-2014.
    Cho S; Han E
    J Clin Lipidol; 2018; 12(2):437-446. PubMed ID: 29452892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia Fact Sheet in South Korea, 2022.
    Jin ES; Shim JS; Kim SE; Bae JH; Kang S; Won JC; Shin MJ; Jin HY; Moon J; Lee H; Kim HC; Jeong IK
    Diabetes Metab J; 2023 Sep; 47(5):632-642. PubMed ID: 37528532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of dyslipidemia in moderate to severe meibomian gland dysfunction.
    Dao AH; Spindle JD; Harp BA; Jacob A; Chuang AZ; Yee RW
    Am J Ophthalmol; 2010 Sep; 150(3):371-375.e1. PubMed ID: 20619393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The non-synonymous Arg230Cys variant (R230C) of the ATP-binding cassette transporter A1 is associated with low HDL cholesterol concentrations in Mexican adults: a population based nation wide study.
    Aguilar-Salinas CA; Canizales-Quinteros S; Rojas-Martínez R; Mehta R; Rodriguez-Guillén R; Ordoñez-Sanchez ML; Riba L; Tusié-Luna MT
    Atherosclerosis; 2011 May; 216(1):146-50. PubMed ID: 21315358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021.
    Khanali J; Ghasemi E; Rashidi MM; Ahmadi N; Ghamari SH; Azangou-Khyavy M; Malekpour MR; Abbasi-Kangevari M; Hashemi SM; Naderian M; Rezaei N; Dilmaghani-Marand A; Farzi Y; Kazemi A; Yoosefi M; Hajebi A; Rezaei S; Azadnajafabad S; Fattahi N; Nasserinejad M; Abdolhamidi E; Haghshenas R; Rezaei N; Djalalinia S; Larijani B; Farzadfar F
    Sci Rep; 2023 Sep; 13(1):15499. PubMed ID: 37726324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006.
    Villalpando S; Shamah-Levy T; Rojas R; Aguilar-Salinas CA
    Salud Publica Mex; 2010; 52 Suppl 1():S72-9. PubMed ID: 20585732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro.
    de Souza LJ; Souto Filho JT; de Souza TF; Reis AF; Gicovate Neto C; Bastos DA; Côrtes VA; Chalita FE; Teixeira CL
    Arq Bras Cardiol; 2003 Sep; 81(3):249-64. PubMed ID: 14569370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence and risk factors of dyslipidemia in a rural population of Henan Province, China].
    Zhou JM; Luo XP; Wang S; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Yang XY; Zhang HY; Han CY; Zhao Y; Li LL; Wang CJ; Feng TP; Zhao JZ; Hu DS; Zhang M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):799-805. PubMed ID: 27655600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.